1-Naphthohydroxamic acid
CAS No. 6953-61-3
1-Naphthohydroxamic acid ( —— )
产品货号. M22068 CAS No. 6953-61-3
1-Naphthohydroxamic acid (Compound 2) is a potent and selective HDAC8 inhibitor with an IC50 of 14 μM, and it is more selectively for HDAC8 than class I HDAC1 and class II HDAC6 (IC50 >100 μM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥413 | 有现货 |
|
10MG | ¥786 | 有现货 |
|
25MG | ¥1563 | 有现货 |
|
50MG | ¥3013 | 有现货 |
|
100MG | ¥4504 | 有现货 |
|
500MG | ¥9882 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称1-Naphthohydroxamic acid
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述1-Naphthohydroxamic acid (Compound 2) is a potent and selective HDAC8 inhibitor with an IC50 of 14 μM, and it is more selectively for HDAC8 than class I HDAC1 and class II HDAC6 (IC50 >100 μM).
-
产品描述1-Naphthohydroxamic acid (Compound 2) is a potent and selective HDAC8 inhibitor with an IC50 of 14 μM, and it is more selectively for HDAC8 than class I HDAC1 and class II HDAC6 (IC50 >100 μM). 1-Naphthohydroxamic acid does not increase global histone H4 acetylation and also does not reduce total intracellular HDAC activity, But it can induce tubulin acetylation. 1-Naphthohydroxamic acid (compound 2; 20-40 μM; 0-144 ?hours; BE(2)-C, SK-N-BE(2) and SH-SY5Y cells) treatment reduces cell numbers in a concentration-dependent manner. 1-Naphthohydroxamic acid reduces the formation of clones in soft-agar concentration dependently.. When either cell type (HeLa and HEK293 cells) is treated with 1-Naphthohydroxamic acid (compound 2; 0.8 μM, 4 μM, 20 μM or 100 μM), only tubulin becomes hyperacetylated[1]. 1-Naphthohydroxamic acid (compound 2) at concentrations in the range of its in vitro IC50 against HDAC8 results in reduced cell density and outgrowth of neurite-like structures that stained positive for neurofilament.1-Naphthohydroxamic acid has the maximum tolerable doses at 50?mg/kg per day. At these concentrations, neither body weight nor blood parameters are critically changed[3]. Dose-limiting toxicities (DLTs) of 1-Naphthohydroxamic acid (compound 2; 0-40 mg/kg; intraperitoneal injection; daily; for 10 day; NMRI Foxn1 nude mice) include weight loss and signs of liver toxicity, as evidenced by elevated plasma liver enzymes and detection of necrotic areas on histological liver examination. Pharmacokinetic studies after intraperitoneal administration of the inhibitors identified the half-life of 1-Naphthohydroxamic acid to be ~15?min, with a plasma peak concentration of ~30?μM.
-
同义词——
-
通路Cell Cycle/DNA Damage
-
靶点HDAC
-
受体HDAC8;HDAC1;HDAC6
-
研究领域——
-
适应症——
化学信息
-
CAS Number6953-61-3
-
分子量187.19
-
分子式C11H9NO2
-
纯度>98% (HPLC)
-
溶解度DMSO:125 mg/mL (667.77 mM; Need ultrasonic)
-
SMILESONC(=O)C1=CC=CC2=CC=CC=C12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Krennhrubec K, et al. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. Bioorg Med Chem Lett. 2007 May 15;17(10):2874-8.
产品手册
关联产品
-
ITSA-1
A small molecule suppressor that counteracts trichostatin A (TSA)-induced cell cycle arrest.
-
EDO-S101
EDO-S101 (Tinostamustine)is a fusion molecule comprising of the alkylator bendamustine and the HDAC-inhibitor vorinostat.
-
Rocilinostat
Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM in a cell-free assay.